China's pharmaceutical industry is now ranked the second largest in the world, and accounts for about 30 percent of the global total of innovative drugs currently under research and development, a senior health official said Friday. Yang Sheng, deputy head of the National Medical Products Administration, made the statement at a press conference in Beijing on high-quality fulfillment of the 14th Five-Year Plan for national socioeconomic development in China in the 2021-2025 period. Yang also highlighted China's comprehensive efforts to ensure drug safety and support high-quality development across the entire pharmaceutical industry chain during the 14th Five-Year Plan period. Shotlist: Beijing, China - Aug 22, 2025: 1. Press briefing in progress; 2. SOUNDBITE (Chinese) Yang Sheng, deputy head of National Medical Products Administration (partially overlaid with shot 3): "At present, China's pharmaceutical industry ranks the second in the world in terms of scale, and the number of innovative drugs under research and development in China has reached about 30 percent of the global total. Since the start of the 14th Five-Year Plan period (2021-2025), the country has approved the marketing of 387 pediatric drugs and 147 drugs for rare diseases, effectively meeting the medication demand of the relevant key groups of the population."; [SHOT OVERLAYING SOUNDBITE] 3. Reporters; [SHOT OVERLAYING SOUNDBITE] FILE: Yunnan Province, southwest China - August 2024 4. Various of production lines of TCM products, researchers at work; 5. Various of researcher working with microscope; image seen through microscope; FILE: Beijing, China - April 2024 6. Sign reading pharmacy; 7. Medicines being dropped to basket; 8. Various of pharmacists dispensing medicine to patients, checking medicine; FILE: China - Date Unknown 9. Various of medical workers working, scanning medical insurance card. [Restriction - No access Chinese mainland]